Petillo Agata, Abruzzese Vittorio, Koshal Prashant, Ostuni Angela, Bisaccia Faustino
Laboratory of Cell Biochemistry, Department of Sciences, University of Basilicata, Potenza, Italy.
Front Mol Biosci. 2020 Nov 12;7:593866. doi: 10.3389/fmolb.2020.593866. eCollection 2020.
The first intermediate in the mitochondrial tricarboxylic acid (TCA) cycle is citrate, which is essential and acts as a metabolic regulator for glycolysis, TCA cycle, gluconeogenesis, and fatty acid synthesis. Within the cytosol, citrate is cleaved by ATP citrate lyase (ACLY) into oxaloacetate (OAA) and acetyl-CoA; OAA can be used for neoglucogenesis or in the TCA cycle, while acetyl-CoA is the precursor of some biosynthetic processes, including the synthesis of fatty acids. Accumulating evidence suggests that citrate is involved in numerous physiological and pathophysiological processes such as inflammation, insulin secretion, neurological disorders, and cancer. Considering the crucial role of citrate to supply the acetyl-CoA pool for fatty acid synthesis and histone acetylation in tumors, in this study we evaluated the effect of citrate added to the growth medium on lipid deposition and histone H4 acetylation in hepatoma cells (HepG2). At low concentration, citrate increased both histone H4 acetylation and lipid deposition; at high concentration, citrate inhibited both, thus suggesting a crucial role of acetyl-CoA availability, which prompted us to investigate the effect of citrate on ACLY. In HepG2 cells, the expression of ACLY is correlated with histone acetylation, which, in turn, depends on citrate concentration. A decrease in H4 acetylation was also observed when citrate was added at a high concentration to immortalized human hepatic cells, whereas ACLY expression was unaffected, indicating a lack of control by histone acetylation. Considering the strong demand for acetyl-CoA but not for OAA in tumor cells, the exogenous citrate would behave like a trojan horse that carries OAA inside the cells and reduces ACLY expression and cellular metabolism. In addition, this study confirmed the already reported dual role of citrate both as a promoter of cell proliferation (at lower concentrations) and as an anticancer agent (at higher concentrations), providing useful tips on the use of citrate for the treatment of tumors.
线粒体三羧酸(TCA)循环的首个中间产物是柠檬酸,它至关重要,并且作为糖酵解、TCA循环、糖异生和脂肪酸合成的代谢调节物发挥作用。在胞质溶胶中,柠檬酸被ATP柠檬酸裂解酶(ACLY)裂解为草酰乙酸(OAA)和乙酰辅酶A;OAA可用于新葡萄糖生成或TCA循环,而乙酰辅酶A是包括脂肪酸合成在内的一些生物合成过程的前体。越来越多的证据表明,柠檬酸参与了众多生理和病理生理过程,如炎症、胰岛素分泌、神经紊乱和癌症。鉴于柠檬酸在肿瘤中为脂肪酸合成和组蛋白乙酰化提供乙酰辅酶A库的关键作用,在本研究中,我们评估了添加到生长培养基中的柠檬酸对肝癌细胞(HepG2)脂质沉积和组蛋白H4乙酰化的影响。在低浓度下,柠檬酸增加了组蛋白H4乙酰化和脂质沉积;在高浓度下,柠檬酸则二者均抑制,这表明乙酰辅酶A可用性的关键作用,促使我们研究柠檬酸对ACLY的影响。在HepG2细胞中,ACLY的表达与组蛋白乙酰化相关,而组蛋白乙酰化又取决于柠檬酸浓度。当向永生化人肝细胞中高浓度添加柠檬酸时,也观察到H4乙酰化降低,而ACLY表达未受影响,这表明缺乏组蛋白乙酰化的调控。鉴于肿瘤细胞对乙酰辅酶A而非OAA有强烈需求,外源性柠檬酸的作用就像一匹特洛伊木马,将OAA带入细胞内并降低ACLY表达和细胞代谢。此外,本研究证实了已报道的柠檬酸作为细胞增殖促进剂(在较低浓度下)和抗癌剂(在较高浓度下)的双重作用,为柠檬酸用于肿瘤治疗提供了有用的提示。